|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2006-8-23
|
|
pubmed:abstractText |
To assess the prognostic significance of persistent low-level viraemia (PLV, defined as persistent plasma viral loads of 51-1000 HIV-1 RNA copies/mL for at least 3 months) in patients who had achieved viral suppression on antiretroviral therapy (ART).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1464-2662
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
437-41
|
|
pubmed:dateRevised |
2007-12-3
|
|
pubmed:meshHeading |
pubmed-meshheading:16925729-Adult,
pubmed-meshheading:16925729-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16925729-Female,
pubmed-meshheading:16925729-HIV Infections,
pubmed-meshheading:16925729-HIV-1,
pubmed-meshheading:16925729-Humans,
pubmed-meshheading:16925729-Male,
pubmed-meshheading:16925729-Prognosis,
pubmed-meshheading:16925729-RNA, Viral,
pubmed-meshheading:16925729-Retrospective Studies,
pubmed-meshheading:16925729-Risk Factors,
pubmed-meshheading:16925729-Treatment Failure,
pubmed-meshheading:16925729-Viral Load,
pubmed-meshheading:16925729-Viremia
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Persistent low-level viraemia and virological failure in HIV-1-infected patients treated with highly active antiretroviral therapy.
|
|
pubmed:affiliation |
Washington University School of Medicine, St Louis, MO, USA. ssungkanuparph@yahoo.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
